NCT01530243View on ClinicalTrials.gov

The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
Disorder of Urinary Stent
Interventions
DRUG

Placebo

same as tolterodine and terazosin dose

DRUG

Terazosine

2 mg BID

DRUG

Tolterodine

2 mg daily

DRUG

Tolterodine + Terazosin

2mg daily and 2mg BID

Trial Locations (1)

Unknown

Imam Khomeini Hospital, Urmia

All Listed Sponsors
lead

Urmia University of Medical Sciences

OTHER

NCT01530243 - The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms | Biotech Hunter | Biotech Hunter